JP2002542162A5 - - Google Patents

Download PDF

Info

Publication number
JP2002542162A5
JP2002542162A5 JP2000611546A JP2000611546A JP2002542162A5 JP 2002542162 A5 JP2002542162 A5 JP 2002542162A5 JP 2000611546 A JP2000611546 A JP 2000611546A JP 2000611546 A JP2000611546 A JP 2000611546A JP 2002542162 A5 JP2002542162 A5 JP 2002542162A5
Authority
JP
Japan
Prior art keywords
acid
embedded image
compound
integer
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000611546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002542162A (ja
Filing date
Publication date
Priority claimed from IT1999MI000751A external-priority patent/IT1311922B1/it
Application filed filed Critical
Publication of JP2002542162A publication Critical patent/JP2002542162A/ja
Publication of JP2002542162A5 publication Critical patent/JP2002542162A5/ja
Pending legal-status Critical Current

Links

JP2000611546A 1999-04-13 2000-04-11 医薬化合物 Pending JP2002542162A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT99A000751 1999-04-13
IT1999MI000751A IT1311922B1 (it) 1999-04-13 1999-04-13 Composti farmaceutici.
PCT/EP2000/003238 WO2000061604A2 (en) 1999-04-13 2000-04-11 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
JP2002542162A JP2002542162A (ja) 2002-12-10
JP2002542162A5 true JP2002542162A5 (https=) 2007-05-10

Family

ID=11382683

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000611546A Pending JP2002542162A (ja) 1999-04-13 2000-04-11 医薬化合物

Country Status (25)

Country Link
US (3) US6909007B1 (https=)
EP (2) EP1475386A3 (https=)
JP (1) JP2002542162A (https=)
KR (2) KR100744701B1 (https=)
CN (2) CN1296380C (https=)
AT (1) ATE274521T1 (https=)
AU (2) AU766798B2 (https=)
BR (1) BR0009696A (https=)
CA (2) CA2370446C (https=)
DE (1) DE60013266T2 (https=)
DK (1) DK1169337T3 (https=)
ES (1) ES2226805T3 (https=)
HU (1) HUP0201872A3 (https=)
IL (2) IL145633A0 (https=)
IT (1) IT1311922B1 (https=)
MX (1) MXPA01010212A (https=)
NO (2) NO323374B1 (https=)
NZ (1) NZ514572A (https=)
PL (1) PL199579B1 (https=)
PT (1) PT1169337E (https=)
RU (1) RU2240325C2 (https=)
SI (1) SI1169337T1 (https=)
TR (2) TR200201899T2 (https=)
WO (1) WO2000061604A2 (https=)
ZA (1) ZA200108124B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393724A1 (en) 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
JP4092203B2 (ja) 2000-12-21 2008-05-28 ニトロメッド，インク． 新規のシクロオキシゲナーゼ２選択的阻害剤としての置換アリール化合物、組成物、および使用方法
IT1320176B1 (it) * 2000-12-22 2003-11-26 Nicox Sa Dispersioni solide di principi attivi nitrati.
EP1219306A1 (en) 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
US6696592B2 (en) 2001-05-22 2004-02-24 Nicox-S.A. Methods of making 21-[4′-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof
ITMI20011307A1 (it) * 2001-06-21 2002-12-21 Nicox Sa Farmaci per l'epilessia
ITMI20020148A1 (it) 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
WO2003103602A2 (en) 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
CA2491127A1 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
AU2003261281A1 (en) 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
CN100513415C (zh) * 2005-08-03 2009-07-15 中国人民解放军军事医学科学院毒物药物研究所 胆汁酸衍生物及其医药用途
EP1940863B1 (en) 2005-09-02 2012-09-05 Nicox S.A. Nitrooxy derivatives of glucocorticoids
US8802726B2 (en) 2006-02-03 2014-08-12 Nicox S.A. Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
US7645749B2 (en) 2006-04-03 2010-01-12 Forbes Medi-Tech Inc. Sterol/stanol nitroderivatives and use thereof
US7645748B2 (en) 2006-04-03 2010-01-12 Forbes Medi-Tech Inc. Sterol/stanol phosphorylnitroderivatives and use thereof
BRPI0807078A2 (pt) * 2007-02-05 2014-04-08 Nicox Sa Composto, e, formulação farmacêutica
US20090087425A1 (en) * 2007-08-10 2009-04-02 Topigen Pharmaceuticals Inc. Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease
US20090088411A1 (en) * 2007-08-31 2009-04-02 Topigen Pharmaceuticals Inc. No-donating corticosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties
EP2214674A4 (en) * 2007-10-19 2011-03-30 Burnham Inst Medical Research INHIBITORS OF ANTI-APOPTOTIC PROTEINS
CN102186873A (zh) 2008-08-05 2011-09-14 尼科克斯公司 用于治疗视网膜和黄斑疾病的新型释放no的甾类化合物
EP2560634A1 (en) 2010-04-23 2013-02-27 Piramal Enterprises Limited Nitric oxide releasing prodrugs of therapeutic agents
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
CA2897571C (en) 2013-01-21 2018-12-18 Apparao Satyam Nitric oxide releasing prodrugs of therapeutic agents containing at least one carboxylic acid group
KR101711513B1 (ko) * 2015-06-26 2017-03-02 주식회사 엘지생활건강 피부 개선용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077750B1 (https=) 1970-02-11 1973-03-16 Clin Byla Ets
GB1458372A (en) 1973-03-05 1976-12-15 Leo Ab Steroid carbamates and allophanates
JPS5845724A (ja) 1981-09-11 1983-03-17 Oriza Yuka Kk オリザノ−ル乳化液の製造法
FR2600653B1 (fr) * 1986-06-24 1988-12-16 Pasteur Strasbourg Universite Composes de synthese associative d'acides amines soufres ou non soufres avec des derives du d-4 pregnene 3,20-dione ou avec des derives du d-1,4 pregnadiene 3,20-dione aux proprietes glucocorticoides et anti-inflammatoires, procedes d'obtention, compositions pharmaceutiques les contenant. proprietes pharmacologiques et applications
IT1204571B (it) * 1987-05-08 1989-03-10 Chiesi Farma Spa Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
DE3856512T2 (de) * 1987-06-29 2002-08-08 Massachusetts Institute Of Technology, Cambridge Nucleotidsequenz für Acetoacetyl-CoA Reduktase kodierend und Verfahren zur Herstellung von Polyester-Biopolymeren
DE4000397A1 (de) 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
JPH04273892A (ja) 1991-02-27 1992-09-30 Kao Corp 新規な２１−置換ステロイド化合物
JP3108474B2 (ja) 1991-08-07 2000-11-13 日清製粉株式会社 活性型ビタミンｄ誘導体
IL104201A0 (en) 1991-12-26 1993-05-13 Wisconsin Alumni Res Found 26,27-dimethylene-1 alpha-25-dihydroxyvitamin d2 and its 24-epimer and pharmaceutical compositions containing them
EP0562497A1 (en) 1992-03-27 1993-09-29 Nisshin Flour Milling Co., Ltd. 1 alpha-hydroxy vitamins D7 and D4' processes for the preparation thereof and pharmaceutical compositions
US5194431A (en) 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
US5707984A (en) 1995-12-08 1998-01-13 G. D. Searle & Co. Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
US5985862A (en) * 1996-05-02 1999-11-16 G.D. Searle & Co. Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
DE19634793A1 (de) 1996-08-29 1998-03-05 Sanol Arznei Schwarz Gmbh S- und O-Nitratoacylverbindungen
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei

Similar Documents

Publication Publication Date Title
JP2002542162A5 (https=)
RU2001127575A (ru) Фармацевтические композиции
Sitruk-Ware et al. Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills
KR100744701B1 (ko) 산화적 손상 및 내피세포 기능부전의 치료를 위한스테로이드 질산염
US6043234A (en) Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen
NO179311B (no) Flerfasekombinasjons- og kontraseptiv pakke
JPS645007B2 (https=)
DE102009034368A1 (de) 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
US6506390B2 (en) Progestogen-anti-progestogen regimens
ITMI962048A1 (it) Composti corticoidei
RU99108661A (ru) Нитроэфиры кортикоидных соединений и их фармацевтические применения
CA2326654A1 (en) Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
US5407926A (en) Ophthalmic composition
DE60101276T2 (de) Zubereitungen für die hormonale Kontrazeption
TOWNSLEY Further studies on the regulation of human placental steroid 3-sulfatase activity
JPH0735395B2 (ja) 新規な骨作用剤
KR950031081A (ko) 마약 또는 마약 혼합물 및 그들을 함유한 조성물의 작용을 자연스럽게 또는 급격히 중단함으로써 나타나는 증상과 관련된 증후군의 예방 또는 치료용 의약의 제조에 사용되는 항글루코코티코이드 활성을 갖는 화합물의 용도
CN1384748A (zh) 作为女性避孕药成分的中孕酮(孕酮受体调节剂)
ES342750A1 (es) Un procedimiento para preparar 21-esteres de esteroides an-ti-inflamatorios de la serie del pregnano.
EP1178807B1 (en) Use of org 33245 in combined intermittent hormone therapy and contraception
LV12942B (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
US7629334B1 (en) Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
GB1191816A (en) Estra-1,3,5 (10),7-Tetraenes and process of preparation
WO2022207631A1 (en) Methods for providing late luteal contraception
EP1957514A1 (de) Prodrugs er-beta-selektiver substanzen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen